Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,068
datasets available to search
ShareScore release 0.9.0
Dataset results
1,068 results for “PD-1”
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
ClinicalTrials.gov study NCT06831175. IPD Sharing: NO. Countries: 1. Publications: 10.
Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
ClinicalTrials.gov study NCT04681287. IPD Sharing: NO. Countries: 1. Publications: 1.
Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1
ClinicalTrials.gov study NCT04130763. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of TATE and PD-1 Inhibitor in Liver Cancer
ClinicalTrials.gov study NCT03259867. IPD Sharing: NO. Countries: 1. Publications: 2.
Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer
ClinicalTrials.gov study NCT04096911. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study
ClinicalTrials.gov study NCT07064668. IPD Sharing: NO. Countries: 1. Publications: 8.
Apatinib Combined With PD-1 in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04350190. IPD Sharing: Not stated. Countries: 1. Publications: 1.
PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.
ClinicalTrials.gov study NCT07053072. IPD Sharing: NO. Countries: 1. Publications: 13.
Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy
ClinicalTrials.gov study NCT04541277. IPD Sharing: NO. Countries: 1. Publications: 2.
Pd-1 Antibody Combined Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer
ClinicalTrials.gov study NCT04516616. IPD Sharing: YES. Countries: 1. Publications: 3.
mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC
ClinicalTrials.gov study NCT04895137. IPD Sharing: NO. Countries: 1. Publications: 12.
PD-1 Blockade Combined with Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients
ClinicalTrials.gov study NCT05060471. IPD Sharing: YES. Countries: 1. Publications: 24.
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
ClinicalTrials.gov study NCT03525782. IPD Sharing: NO. Countries: 1. Publications: 1.
CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT03182816. IPD Sharing: NO. Countries: 1. Publications: 1.
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
ClinicalTrials.gov study NCT04636775. IPD Sharing: NO. Countries: 1. Publications: 2.
Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer
ClinicalTrials.gov study NCT05420584. IPD Sharing: Not stated. Countries: 1. Publications: 3.
FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis
ClinicalTrials.gov study NCT04886193. IPD Sharing: NO. Countries: 1. Publications: 14.
PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP
ClinicalTrials.gov study NCT04848597. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sintilimab (PD-1 Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT03700476. IPD Sharing: YES. Countries: 1. Publications: 3.
PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML
ClinicalTrials.gov study NCT04722952. IPD Sharing: NO. Countries: 1. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.